면역치료제 시장 분석 및 예측(-2033년) : 유형별, 제품별, 용도별, 기술별, 최종사용자별, 프로세스별, 모드별, 단계별

The immunotherapy drugs market is estimated to expand from $163 billion in 2023 to $375 billion by 2033, with a compound annual growth rate (CAGR) of 8.5%.

The Immunotherapy Drugs Market encompasses the industry dedicated to developing and commercializing therapeutic agents that harness and enhance the body's immune system to combat diseases, notably cancer and autoimmune disorders. This market includes monoclonal antibodies, checkpoint inhibitors, vaccines, and cell therapies, representing a paradigm shift towards personalized medicine and offering promising avenues for improved patient outcomes and innovative treatment modalities.

The market is witnessing growth, primarily driven by advancements in cancer treatment and autoimmune disease management. Monoclonal antibodies lead the market, owing to their targeted action and efficacy in treating various cancers. Checkpoint inhibitors are the second highest performing sub-segment, gaining traction due to their ability to unleash the body's immune response against tumors. The North American region dominates the market, supported by strong healthcare infrastructure and significant R&D investments. Europe follows closely, bolstered by favorable government policies and increased adoption of novel therapies. Within these regions, the United States and Germany are the top-performing countries, reflecting their commitment to innovation and access to advanced healthcare solutions. The Asia-Pacific region is emerging as a lucrative market, driven by increasing healthcare expenditure and a growing patient population, particularly in China and India. These insights underscore the dynamic nature of the immunotherapy drugs market and the promising opportunities it presents.

In 2023, the Immunotherapy Drugs Market demonstrated robust growth, with the market volume reaching 320 million units. The monoclonal antibodies segment holds the largest market share at 45%, followed by immune checkpoint inhibitors at 30%, and cancer vaccines at 25%. This distribution reflects the increasing adoption of targeted therapies and the rising incidence of cancer worldwide. The monoclonal antibodies segment is particularly driven by advancements in biotechnology and personalized medicine.

The competitive landscape is dominated by key players such as Roche, Merck & Co., and Bristol-Myers Squibb, each leveraging strategic partnerships and innovative R&D to enhance their market positions. Regulatory influences, including FDA approvals and patent laws, significantly impact market dynamics. The market is poised for expansion, with opportunities in emerging markets and the development of novel immunotherapeutic agents. However, challenges such as high treatment costs and stringent regulatory requirements persist. The integration of artificial intelligence in drug development is expected to further propel growth.

North America dominates the immunotherapy drugs market, primarily driven by the United States. The region benefits from a robust healthcare infrastructure and significant investment in research and development. The presence of leading pharmaceutical companies and a strong focus on innovation further bolster this market. The high prevalence of chronic diseases in the region also fuels demand for advanced treatment options.

Europe holds a substantial share in the immunotherapy drugs market, with Germany, France, and the United Kingdom being key contributors. The region's well-established healthcare system and strong regulatory framework support market growth. European countries are also investing in personalized medicine, which enhances the adoption of immunotherapy drugs. The emphasis on cancer research and treatment innovation is a driving force in this region.

Asia Pacific is experiencing rapid growth in the immunotherapy drugs market. Rising healthcare expenditures and increasing awareness about advanced treatments contribute to this expansion. Countries like China and India are investing in healthcare infrastructure and research initiatives. The growing prevalence of cancer and other chronic diseases in these countries increases the demand for effective immunotherapy treatments.

Latin America and the Middle East & Africa regions are gradually emerging in the immunotherapy drugs market. Although these regions currently hold a smaller market share, increasing healthcare investments and improving access to advanced medical treatments are expected to drive growth. Governments in these regions are focusing on enhancing healthcare facilities and promoting research to support market development.

Key Companies

Incyte, Bei Gene, Macro Genics, Adaptimmune Therapeutics, Immunomedics, Kite Pharma, Juno Therapeutics, Immunocore, Bluebird Bio, Celldex Therapeutics, Onco Med Pharmaceuticals, Argenx, Cellectis, Fate Therapeutics, Gritstone Oncology, Adaptimmune, Allogene Therapeutics, Iovance Biotherapeutics, Zymeworks, Compugen

Sources

World Health Organization (WHO), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institutes of Health (NIH), American Association for Cancer Research (AACR), International Agency for Research on Cancer (IARC), Centers for Disease Control and Prevention (CDC), World Cancer Research Fund International, International Society for Biological Therapy of Cancer (iSBTc), Cancer Research UK, National Cancer Institute (NCI), European Society for Medical Oncology (ESMO), Society for Immunotherapy of Cancer (SITC), National Comprehensive Cancer Network (NCCN), American Society of Clinical Oncology (ASCO), Australian Therapeutic Goods Administration (TGA), Canadian Agency for Drugs and Technologies in Health (CADTH), International Conference on Cancer Immunotherapy, International Immunocompromised Host Society (ICHS), International Cancer Immunotherapy Conference (CICON).

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Immunotherapy Drugs Market Overview

• 1.1 Objectives of the Study
• 1.2 Immunotherapy Drugs Market Definition and Scope of the Report
• 1.3 Report Limitations
• 1.4 Years & Currency Considered in the Study
• 1.5 Research Methodologies
  • 1.5.1 Secondary Research
  • 1.5.2 Primary Research
  • 1.5.3 Market Size Estimation: Top-Down Approach
  • 1.5.4 Market Size Estimation: Bottom-Up Approach
  • 1.5.5 Data Triangulation and Validation

2: Executive Summary

• 2.1 Summary
• 2.2 Key Opinion Leaders
• 2.3 Key Highlights of the Market, by Type
• 2.4 Key Highlights of the Market, by Product
• 2.5 Key Highlights of the Market, by Application
• 2.6 Key Highlights of the Market, by Technology
• 2.7 Key Highlights of the Market, by End User
• 2.8 Key Highlights of the Market, by Process
• 2.9 Key Highlights of the Market, by Mode
• 2.10 Key Highlights of the Market, by Stage
• 2.11 Key Highlights of the Market, by North America
• 2.12 Key Highlights of the Market, by Europe
• 2.13 Key Highlights of the Market, by Asia-Pacific
• 2.14 Key Highlights of the Market, by Latin America
• 2.15 Key Highlights of the Market, by Middle East
• 2.16 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

• 3.1 Market Attractiveness Analysis, by Region
• 3.2 Market Attractiveness Analysis, by Type
• 3.3 Market Attractiveness Analysis, by Product
• 3.4 Market Attractiveness Analysis, by Application
• 3.5 Market Attractiveness Analysis, by Technology
• 3.6 Market Attractiveness Analysis, by End User
• 3.7 Market Attractiveness Analysis, by Process
• 3.8 Market Attractiveness Analysis, by Mode
• 3.9 Market Attractiveness Analysis, by Stage
• 3.10 Market Attractiveness Analysis, by North America
• 3.11 Market Attractiveness Analysis, by Europe
• 3.12 Market Attractiveness Analysis, by Asia-Pacific
• 3.13 Market Attractiveness Analysis, by Latin America
• 3.14 Market Attractiveness Analysis, by Middle East
• 3.15 Market Attractiveness Analysis, by Africa

4: Immunotherapy Drugs Market Outlook

• 4.1 Immunotherapy Drugs Market Segmentation
• 4.2 Market Dynamics
  • 4.2.1 Market Drivers
  • 4.2.2 Market Trends
  • 4.2.3 Market Restraints
  • 4.2.4 Market Opportunities
• 4.3 Porters Five Forces Analysis
  • 4.3.1 Threat of New Entrants
  • 4.3.2 Threat of Substitutes
  • 4.3.3 Bargaining Power of Buyers
  • 4.3.4 Bargaining Power of Supplier
  • 4.3.5 Competitive Rivalry
• 4.4 PESTLE Analysis
• 4.5 Value Chain Analysis
• 4.6 4Ps Model
• 4.7 ANSOFF Matrix

5: Immunotherapy Drugs Immunotherapy Drugs Market Strategy

• 5.1 Parent Market Analysis
• 5.2 Supply-Demand Analysis
• 5.3 Consumer Buying Interest
• 5.4 Case Study Analysis
• 5.5 Pricing Analysis
• 5.6 Regulatory Landscape
• 5.7 Supply Chain Analysis
• 5.8 Competition Product Analysis
• 5.9 Recent Developments

6: Immunotherapy Drugs Market Size

• 6.1 Immunotherapy Drugs Market Size, by Value
• 6.2 Immunotherapy Drugs Market Size, by Volume

7: Immunotherapy Drugs Market, by Type

• 7.1 Market Overview
• 7.2 Monoclonal Antibodies
  • 7.2.1 Key Market Trends & Opportunity Analysis
  • 7.2.2 Market Size and Forecast, by Region
• 7.3 Checkpoint Inhibitors
  • 7.3.1 Key Market Trends & Opportunity Analysis
  • 7.3.2 Market Size and Forecast, by Region
• 7.4 Cytokines
  • 7.4.1 Key Market Trends & Opportunity Analysis
  • 7.4.2 Market Size and Forecast, by Region
• 7.5 Cancer Vaccines
  • 7.5.1 Key Market Trends & Opportunity Analysis
  • 7.5.2 Market Size and Forecast, by Region
• 7.6 Adoptive Cell Therapy
  • 7.6.1 Key Market Trends & Opportunity Analysis
  • 7.6.2 Market Size and Forecast, by Region
• 7.7 Oncolytic Virus Therapy
  • 7.7.1 Key Market Trends & Opportunity Analysis
  • 7.7.2 Market Size and Forecast, by Region
• 7.8 Others
  • 7.8.1 Key Market Trends & Opportunity Analysis
  • 7.8.2 Market Size and Forecast, by Region

8: Immunotherapy Drugs Market, by Product

• 8.1 Market Overview
• 8.2 Therapeutic Vaccines
  • 8.2.1 Key Market Trends & Opportunity Analysis
  • 8.2.2 Market Size and Forecast, by Region
• 8.3 Immune Checkpoint Inhibitors
  • 8.3.1 Key Market Trends & Opportunity Analysis
  • 8.3.2 Market Size and Forecast, by Region
• 8.4 Non-specific Immunotherapies
  • 8.4.1 Key Market Trends & Opportunity Analysis
  • 8.4.2 Market Size and Forecast, by Region
• 8.5 Oncolytic Virus Immunotherapy
  • 8.5.1 Key Market Trends & Opportunity Analysis
  • 8.5.2 Market Size and Forecast, by Region
• 8.6 CAR-T Cell Therapy
  • 8.6.1 Key Market Trends & Opportunity Analysis
  • 8.6.2 Market Size and Forecast, by Region
• 8.7 Others
  • 8.7.1 Key Market Trends & Opportunity Analysis
  • 8.7.2 Market Size and Forecast, by Region

9: Immunotherapy Drugs Market, by Application

• 9.1 Market Overview
• 9.2 Cancer
  • 9.2.1 Key Market Trends & Opportunity Analysis
  • 9.2.2 Market Size and Forecast, by Region
• 9.3 Autoimmune Diseases
  • 9.3.1 Key Market Trends & Opportunity Analysis
  • 9.3.2 Market Size and Forecast, by Region
• 9.4 Infectious Diseases
  • 9.4.1 Key Market Trends & Opportunity Analysis
  • 9.4.2 Market Size and Forecast, by Region
• 9.5 Inflammatory Diseases
  • 9.5.1 Key Market Trends & Opportunity Analysis
  • 9.5.2 Market Size and Forecast, by Region
• 9.6 Others
  • 9.6.1 Key Market Trends & Opportunity Analysis
  • 9.6.2 Market Size and Forecast, by Region

10: Immunotherapy Drugs Market, by Technology

• 10.1 Market Overview
• 10.2 Gene Editing
  • 10.2.1 Key Market Trends & Opportunity Analysis
  • 10.2.2 Market Size and Forecast, by Region
• 10.3 CRISPR
  • 10.3.1 Key Market Trends & Opportunity Analysis
  • 10.3.2 Market Size and Forecast, by Region
• 10.4 RNA Interference
  • 10.4.1 Key Market Trends & Opportunity Analysis
  • 10.4.2 Market Size and Forecast, by Region
• 10.5 Nanotechnology
  • 10.5.1 Key Market Trends & Opportunity Analysis
  • 10.5.2 Market Size and Forecast, by Region
• 10.6 Recombinant DNA Technology
  • 10.6.1 Key Market Trends & Opportunity Analysis
  • 10.6.2 Market Size and Forecast, by Region
• 10.7 Others
  • 10.7.1 Key Market Trends & Opportunity Analysis
  • 10.7.2 Market Size and Forecast, by Region

11: Immunotherapy Drugs Market, by End User

• 11.1 Market Overview
• 11.2 Hospitals
  • 11.2.1 Key Market Trends & Opportunity Analysis
  • 11.2.2 Market Size and Forecast, by Region
• 11.3 Clinics
  • 11.3.1 Key Market Trends & Opportunity Analysis
  • 11.3.2 Market Size and Forecast, by Region
• 11.4 Research Institutes
  • 11.4.1 Key Market Trends & Opportunity Analysis
  • 11.4.2 Market Size and Forecast, by Region
• 11.5 Biopharmaceutical Companies
  • 11.5.1 Key Market Trends & Opportunity Analysis
  • 11.5.2 Market Size and Forecast, by Region
• 11.6 Others
  • 11.6.1 Key Market Trends & Opportunity Analysis
  • 11.6.2 Market Size and Forecast, by Region

12: Immunotherapy Drugs Market, by Process

• 12.1 Market Overview
• 12.2 Manufacturing
  • 12.2.1 Key Market Trends & Opportunity Analysis
  • 12.2.2 Market Size and Forecast, by Region
• 12.3 Research and Development
  • 12.3.1 Key Market Trends & Opportunity Analysis
  • 12.3.2 Market Size and Forecast, by Region
• 12.4 Clinical Trials
  • 12.4.1 Key Market Trends & Opportunity Analysis
  • 12.4.2 Market Size and Forecast, by Region
• 12.5 Regulatory Approval
  • 12.5.1 Key Market Trends & Opportunity Analysis
  • 12.5.2 Market Size and Forecast, by Region
• 12.6 Commercialization
  • 12.6.1 Key Market Trends & Opportunity Analysis
  • 12.6.2 Market Size and Forecast, by Region
• 12.7 Others
  • 12.7.1 Key Market Trends & Opportunity Analysis
  • 12.7.2 Market Size and Forecast, by Region

13: Immunotherapy Drugs Market, by Mode

• 13.1 Market Overview
• 13.2 Intravenous
  • 13.2.1 Key Market Trends & Opportunity Analysis
  • 13.2.2 Market Size and Forecast, by Region
• 13.3 Oral
  • 13.3.1 Key Market Trends & Opportunity Analysis
  • 13.3.2 Market Size and Forecast, by Region
• 13.4 Topical
  • 13.4.1 Key Market Trends & Opportunity Analysis
  • 13.4.2 Market Size and Forecast, by Region
• 13.5 Inhalation
  • 13.5.1 Key Market Trends & Opportunity Analysis
  • 13.5.2 Market Size and Forecast, by Region
• 13.6 Others
  • 13.6.1 Key Market Trends & Opportunity Analysis
  • 13.6.2 Market Size and Forecast, by Region

14: Immunotherapy Drugs Market, by Stage

• 14.1 Market Overview
• 14.2 Discovery
  • 14.2.1 Key Market Trends & Opportunity Analysis
  • 14.2.2 Market Size and Forecast, by Region
• 14.3 Preclinical
  • 14.3.1 Key Market Trends & Opportunity Analysis
  • 14.3.2 Market Size and Forecast, by Region
• 14.4 Clinical
  • 14.4.1 Key Market Trends & Opportunity Analysis
  • 14.4.2 Market Size and Forecast, by Region
• 14.5 Approval
  • 14.5.1 Key Market Trends & Opportunity Analysis
  • 14.5.2 Market Size and Forecast, by Region
• 14.6 Launch
  • 14.6.1 Key Market Trends & Opportunity Analysis
  • 14.6.2 Market Size and Forecast, by Region
• 14.7 Post-market Surveillance
  • 14.7.1 Key Market Trends & Opportunity Analysis
  • 14.7.2 Market Size and Forecast, by Region
• 14.8 Others
  • 14.8.1 Key Market Trends & Opportunity Analysis
  • 14.8.2 Market Size and Forecast, by Region

15: Immunotherapy Drugs Market, by Region

• 15.1 Overview
• 15.2 North America
  • 15.2.1 Key Market Trends and Opportunities
  • 15.2.2 North America Market Size and Forecast, by Type
  • 15.2.3 North America Market Size and Forecast, by Product
  • 15.2.4 North America Market Size and Forecast, by Application
  • 15.2.5 North America Market Size and Forecast, by Technology
  • 15.2.6 North America Market Size and Forecast, by End User
  • 15.2.7 North America Market Size and Forecast, by Process
  • 15.2.8 North America Market Size and Forecast, by Mode
  • 15.2.9 North America Market Size and Forecast, by Stage
  • 15.2.10 North America Market Size and Forecast, by Country
  • 15.2.11 United States
    • 15.2.9.1 United States Market Size and Forecast, by Type
    • 15.2.9.2 United States Market Size and Forecast, by Product
    • 15.2.9.3 United States Market Size and Forecast, by Application
    • 15.2.9.4 United States Market Size and Forecast, by Technology
    • 15.2.9.5 United States Market Size and Forecast, by End User
    • 15.2.9.6 United States Market Size and Forecast, by Process
    • 15.2.9.7 United States Market Size and Forecast, by Mode
    • 15.2.9.8 United States Market Size and Forecast, by Stage
    • 15.2.9.9 Local Competition Analysis
    • 15.2.9.10 Local Market Analysis
  • 15.2.1 Canada
    • 15.2.10.1 Canada Market Size and Forecast, by Type
    • 15.2.10.2 Canada Market Size and Forecast, by Product
    • 15.2.10.3 Canada Market Size and Forecast, by Application
    • 15.2.10.4 Canada Market Size and Forecast, by Technology
    • 15.2.10.5 Canada Market Size and Forecast, by End User
    • 15.2.10.6 Canada Market Size and Forecast, by Process
    • 15.2.10.7 Canada Market Size and Forecast, by Mode
    • 15.2.10.8 Canada Market Size and Forecast, by Stage
    • 15.2.10.9 Local Competition Analysis
    • 15.2.10.10 Local Market Analysis
• 15.1 Europe
  • 15.3.1 Key Market Trends and Opportunities
  • 15.3.2 Europe Market Size and Forecast, by Type
  • 15.3.3 Europe Market Size and Forecast, by Product
  • 15.3.4 Europe Market Size and Forecast, by Application
  • 15.3.5 Europe Market Size and Forecast, by Technology
  • 15.3.6 Europe Market Size and Forecast, by End User
  • 15.3.7 Europe Market Size and Forecast, by Process
  • 15.3.8 Europe Market Size and Forecast, by Mode
  • 15.3.9 Europe Market Size and Forecast, by Stage
  • 15.3.10 Europe Market Size and Forecast, by Country
  • 15.3.11 United Kingdom
    • 15.3.9.1 United Kingdom Market Size and Forecast, by Type
    • 15.3.9.2 United Kingdom Market Size and Forecast, by Product
    • 15.3.9.3 United Kingdom Market Size and Forecast, by Application
    • 15.3.9.4 United Kingdom Market Size and Forecast, by Technology
    • 15.3.9.5 United Kingdom Market Size and Forecast, by End User
    • 15.3.9.6 United Kingdom Market Size and Forecast, by Process
    • 15.3.9.7 United Kingdom Market Size and Forecast, by Mode
    • 15.3.9.8 United Kingdom Market Size and Forecast, by Stage
    • 15.3.9.9 Local Competition Analysis
    • 15.3.9.10 Local Market Analysis
  • 15.3.1 Germany
    • 15.3.10.1 Germany Market Size and Forecast, by Type
    • 15.3.10.2 Germany Market Size and Forecast, by Product
    • 15.3.10.3 Germany Market Size and Forecast, by Application
    • 15.3.10.4 Germany Market Size and Forecast, by Technology
    • 15.3.10.5 Germany Market Size and Forecast, by End User
    • 15.3.10.6 Germany Market Size and Forecast, by Process
    • 15.3.10.7 Germany Market Size and Forecast, by Mode
    • 15.3.10.8 Germany Market Size and Forecast, by Stage
    • 15.3.10.9 Local Competition Analysis
    • 15.3.10.10 Local Market Analysis
  • 15.3.1 France
    • 15.3.11.1 France Market Size and Forecast, by Type
    • 15.3.11.2 France Market Size and Forecast, by Product
    • 15.3.11.3 France Market Size and Forecast, by Application
    • 15.3.11.4 France Market Size and Forecast, by Technology
    • 15.3.11.5 France Market Size and Forecast, by End User
    • 15.3.11.6 France Market Size and Forecast, by Process
    • 15.3.11.7 France Market Size and Forecast, by Mode
    • 15.3.11.8 France Market Size and Forecast, by Stage
    • 15.3.11.9 Local Competition Analysis
    • 15.3.11.10 Local Market Analysis
  • 15.3.1 Spain
    • 15.3.12.1 Spain Market Size and Forecast, by Type
    • 15.3.12.2 Spain Market Size and Forecast, by Product
    • 15.3.12.3 Spain Market Size and Forecast, by Application
    • 15.3.12.4 Spain Market Size and Forecast, by Technology
    • 15.3.12.5 Spain Market Size and Forecast, by End User
    • 15.3.12.6 Spain Market Size and Forecast, by Process
    • 15.3.12.7 Spain Market Size and Forecast, by Mode
    • 15.3.12.8 Spain Market Size and Forecast, by Stage
    • 15.3.12.9 Local Competition Analysis
    • 15.3.12.10 Local Market Analysis
  • 15.3.1 Italy
    • 15.3.13.1 Italy Market Size and Forecast, by Type
    • 15.3.13.2 Italy Market Size and Forecast, by Product
    • 15.3.13.3 Italy Market Size and Forecast, by Application
    • 15.3.13.4 Italy Market Size and Forecast, by Technology
    • 15.3.13.5 Italy Market Size and Forecast, by End User
    • 15.3.13.6 Italy Market Size and Forecast, by Process
    • 15.3.13.7 Italy Market Size and Forecast, by Mode
    • 15.3.13.8 Italy Market Size and Forecast, by Stage
    • 15.3.13.9 Local Competition Analysis
    • 15.3.13.10 Local Market Analysis
  • 15.3.1 Netherlands
    • 15.3.14.1 Netherlands Market Size and Forecast, by Type
    • 15.3.14.2 Netherlands Market Size and Forecast, by Product
    • 15.3.14.3 Netherlands Market Size and Forecast, by Application
    • 15.3.14.4 Netherlands Market Size and Forecast, by Technology
    • 15.3.14.5 Netherlands Market Size and Forecast, by End User
    • 15.3.14.6 Netherlands Market Size and Forecast, by Process
    • 15.3.14.7 Netherlands Market Size and Forecast, by Mode
    • 15.3.14.8 Netherlands Market Size and Forecast, by Stage
    • 15.3.14.9 Local Competition Analysis
    • 15.3.14.10 Local Market Analysis
  • 15.3.1 Sweden
    • 15.3.15.1 Sweden Market Size and Forecast, by Type
    • 15.3.15.2 Sweden Market Size and Forecast, by Product
    • 15.3.15.3 Sweden Market Size and Forecast, by Application
    • 15.3.15.4 Sweden Market Size and Forecast, by Technology
    • 15.3.15.5 Sweden Market Size and Forecast, by End User
    • 15.3.15.6 Sweden Market Size and Forecast, by Process
    • 15.3.15.7 Sweden Market Size and Forecast, by Mode
    • 15.3.15.8 Sweden Market Size and Forecast, by Stage
    • 15.3.15.9 Local Competition Analysis
    • 15.3.15.10 Local Market Analysis
  • 15.3.1 Switzerland
    • 15.3.16.1 Switzerland Market Size and Forecast, by Type
    • 15.3.16.2 Switzerland Market Size and Forecast, by Product
    • 15.3.16.3 Switzerland Market Size and Forecast, by Application
    • 15.3.16.4 Switzerland Market Size and Forecast, by Technology
    • 15.3.16.5 Switzerland Market Size and Forecast, by End User
    • 15.3.16.6 Switzerland Market Size and Forecast, by Process
    • 15.3.16.7 Switzerland Market Size and Forecast, by Mode
    • 15.3.16.8 Switzerland Market Size and Forecast, by Stage
    • 15.3.16.9 Local Competition Analysis
    • 15.3.16.10 Local Market Analysis
  • 15.3.1 Denmark
    • 15.3.17.1 Denmark Market Size and Forecast, by Type
    • 15.3.17.2 Denmark Market Size and Forecast, by Product
    • 15.3.17.3 Denmark Market Size and Forecast, by Application
    • 15.3.17.4 Denmark Market Size and Forecast, by Technology
    • 15.3.17.5 Denmark Market Size and Forecast, by End User
    • 15.3.17.6 Denmark Market Size and Forecast, by Process
    • 15.3.17.7 Denmark Market Size and Forecast, by Mode
    • 15.3.17.8 Denmark Market Size and Forecast, by Stage
    • 15.3.17.9 Local Competition Analysis
    • 15.3.17.10 Local Market Analysis
  • 15.3.1 Finland
    • 15.3.18.1 Finland Market Size and Forecast, by Type
    • 15.3.18.2 Finland Market Size and Forecast, by Product
    • 15.3.18.3 Finland Market Size and Forecast, by Application
    • 15.3.18.4 Finland Market Size and Forecast, by Technology
    • 15.3.18.5 Finland Market Size and Forecast, by End User
    • 15.3.18.6 Finland Market Size and Forecast, by Process
    • 15.3.18.7 Finland Market Size and Forecast, by Mode
    • 15.3.18.8 Finland Market Size and Forecast, by Stage
    • 15.3.18.9 Local Competition Analysis
    • 15.3.18.10 Local Market Analysis
  • 15.3.1 Russia
    • 15.3.19.1 Russia Market Size and Forecast, by Type
    • 15.3.19.2 Russia Market Size and Forecast, by Product
    • 15.3.19.3 Russia Market Size and Forecast, by Application
    • 15.3.19.4 Russia Market Size and Forecast, by Technology
    • 15.3.19.5 Russia Market Size and Forecast, by End User
    • 15.3.19.6 Russia Market Size and Forecast, by Process
    • 15.3.19.7 Russia Market Size and Forecast, by Mode
    • 15.3.19.8 Russia Market Size and Forecast, by Stage
    • 15.3.19.9 Local Competition Analysis
    • 15.3.19.10 Local Market Analysis
  • 15.3.1 Rest of Europe
    • 15.3.20.1 Rest of Europe Market Size and Forecast, by Type
    • 15.3.20.2 Rest of Europe Market Size and Forecast, by Product
    • 15.3.20.3 Rest of Europe Market Size and Forecast, by Application
    • 15.3.20.4 Rest of Europe Market Size and Forecast, by Technology
    • 15.3.20.5 Rest of Europe Market Size and Forecast, by End User
    • 15.3.20.6 Rest of Europe Market Size and Forecast, by Process
    • 15.3.20.7 Rest of Europe Market Size and Forecast, by Mode
    • 15.3.20.8 Rest of Europe Market Size and Forecast, by Stage
    • 15.3.20.9 Local Competition Analysis
    • 15.3.20.10 Local Market Analysis
• 15.1 Asia-Pacific
  • 15.4.1 Key Market Trends and Opportunities
  • 15.4.2 Asia-Pacific Market Size and Forecast, by Type
  • 15.4.3 Asia-Pacific Market Size and Forecast, by Product
  • 15.4.4 Asia-Pacific Market Size and Forecast, by Application
  • 15.4.5 Asia-Pacific Market Size and Forecast, by Technology
  • 15.4.6 Asia-Pacific Market Size and Forecast, by End User
  • 15.4.7 Asia-Pacific Market Size and Forecast, by Process
  • 15.4.8 Asia-Pacific Market Size and Forecast, by Mode
  • 15.4.9 Asia-Pacific Market Size and Forecast, by Stage
  • 15.4.10 Asia-Pacific Market Size and Forecast, by Country
  • 15.4.11 China
    • 15.4.9.1 China Market Size and Forecast, by Type
    • 15.4.9.2 China Market Size and Forecast, by Product
    • 15.4.9.3 China Market Size and Forecast, by Application
    • 15.4.9.4 China Market Size and Forecast, by Technology
    • 15.4.9.5 China Market Size and Forecast, by End User
    • 15.4.9.6 China Market Size and Forecast, by Process
    • 15.4.9.7 China Market Size and Forecast, by Mode
    • 15.4.9.8 China Market Size and Forecast, by Stage
    • 15.4.9.9 Local Competition Analysis
    • 15.4.9.10 Local Market Analysis
  • 15.4.1 India
    • 15.4.10.1 India Market Size and Forecast, by Type
    • 15.4.10.2 India Market Size and Forecast, by Product
    • 15.4.10.3 India Market Size and Forecast, by Application
    • 15.4.10.4 India Market Size and Forecast, by Technology
    • 15.4.10.5 India Market Size and Forecast, by End User
    • 15.4.10.6 India Market Size and Forecast, by Process
    • 15.4.10.7 India Market Size and Forecast, by Mode
    • 15.4.10.8 India Market Size and Forecast, by Stage
    • 15.4.10.9 Local Competition Analysis
    • 15.4.10.10 Local Market Analysis
  • 15.4.1 Japan
    • 15.4.11.1 Japan Market Size and Forecast, by Type
    • 15.4.11.2 Japan Market Size and Forecast, by Product
    • 15.4.11.3 Japan Market Size and Forecast, by Application
    • 15.4.11.4 Japan Market Size and Forecast, by Technology
    • 15.4.11.5 Japan Market Size and Forecast, by End User
    • 15.4.11.6 Japan Market Size and Forecast, by Process
    • 15.4.11.7 Japan Market Size and Forecast, by Mode
    • 15.4.11.8 Japan Market Size and Forecast, by Stage
    • 15.4.11.9 Local Competition Analysis
    • 15.4.11.10 Local Market Analysis
  • 15.4.1 South Korea
    • 15.4.12.1 South Korea Market Size and Forecast, by Type
    • 15.4.12.2 South Korea Market Size and Forecast, by Product
    • 15.4.12.3 South Korea Market Size and Forecast, by Application
    • 15.4.12.4 South Korea Market Size and Forecast, by Technology
    • 15.4.12.5 South Korea Market Size and Forecast, by End User
    • 15.4.12.6 South Korea Market Size and Forecast, by Process
    • 15.4.12.7 South Korea Market Size and Forecast, by Mode
    • 15.4.12.8 South Korea Market Size and Forecast, by Stage
    • 15.4.12.9 Local Competition Analysis
    • 15.4.12.10 Local Market Analysis
  • 15.4.1 Australia
    • 15.4.13.1 Australia Market Size and Forecast, by Type
    • 15.4.13.2 Australia Market Size and Forecast, by Product
    • 15.4.13.3 Australia Market Size and Forecast, by Application
    • 15.4.13.4 Australia Market Size and Forecast, by Technology
    • 15.4.13.5 Australia Market Size and Forecast, by End User
    • 15.4.13.6 Australia Market Size and Forecast, by Process
    • 15.4.13.7 Australia Market Size and Forecast, by Mode
    • 15.4.13.8 Australia Market Size and Forecast, by Stage
    • 15.4.13.9 Local Competition Analysis
    • 15.4.13.10 Local Market Analysis
  • 15.4.1 Singapore
    • 15.4.14.1 Singapore Market Size and Forecast, by Type
    • 15.4.14.2 Singapore Market Size and Forecast, by Product
    • 15.4.14.3 Singapore Market Size and Forecast, by Application
    • 15.4.14.4 Singapore Market Size and Forecast, by Technology
    • 15.4.14.5 Singapore Market Size and Forecast, by End User
    • 15.4.14.6 Singapore Market Size and Forecast, by Process
    • 15.4.14.7 Singapore Market Size and Forecast, by Mode
    • 15.4.14.8 Singapore Market Size and Forecast, by Stage
    • 15.4.14.9 Local Competition Analysis
    • 15.4.14.10 Local Market Analysis
  • 15.4.1 Indonesia
    • 15.4.15.1 Indonesia Market Size and Forecast, by Type
    • 15.4.15.2 Indonesia Market Size and Forecast, by Product
    • 15.4.15.3 Indonesia Market Size and Forecast, by Application
    • 15.4.15.4 Indonesia Market Size and Forecast, by Technology
    • 15.4.15.5 Indonesia Market Size and Forecast, by End User
    • 15.4.15.6 Indonesia Market Size and Forecast, by Process
    • 15.4.15.7 Indonesia Market Size and Forecast, by Mode
    • 15.4.15.8 Indonesia Market Size and Forecast, by Stage
    • 15.4.15.9 Local Competition Analysis
    • 15.4.15.10 Local Market Analysis
  • 15.4.1 Taiwan
    • 15.4.16.1 Taiwan Market Size and Forecast, by Type
    • 15.4.16.2 Taiwan Market Size and Forecast, by Product
    • 15.4.16.3 Taiwan Market Size and Forecast, by Application
    • 15.4.16.4 Taiwan Market Size and Forecast, by Technology
    • 15.4.16.5 Taiwan Market Size and Forecast, by End User
    • 15.4.16.6 Taiwan Market Size and Forecast, by Process
    • 15.4.16.7 Taiwan Market Size and Forecast, by Mode
    • 15.4.16.8 Taiwan Market Size and Forecast, by Stage
    • 15.4.16.9 Local Competition Analysis
    • 15.4.16.10 Local Market Analysis
  • 15.4.1 Malaysia
    • 15.4.17.1 Malaysia Market Size and Forecast, by Type
    • 15.4.17.2 Malaysia Market Size and Forecast, by Product
    • 15.4.17.3 Malaysia Market Size and Forecast, by Application
    • 15.4.17.4 Malaysia Market Size and Forecast, by Technology
    • 15.4.17.5 Malaysia Market Size and Forecast, by End User
    • 15.4.17.6 Malaysia Market Size and Forecast, by Process
    • 15.4.17.7 Malaysia Market Size and Forecast, by Mode
    • 15.4.17.8 Malaysia Market Size and Forecast, by Stage
    • 15.4.17.9 Local Competition Analysis
    • 15.4.17.10 Local Market Analysis
  • 15.4.1 Rest of Asia-Pacific
    • 15.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
    • 15.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
    • 15.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
    • 15.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
    • 15.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
    • 15.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
    • 15.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Mode
    • 15.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Stage
    • 15.4.18.9 Local Competition Analysis
    • 15.4.18.10 Local Market Analysis
• 15.1 Latin America
  • 15.5.1 Key Market Trends and Opportunities
  • 15.5.2 Latin America Market Size and Forecast, by Type
  • 15.5.3 Latin America Market Size and Forecast, by Product
  • 15.5.4 Latin America Market Size and Forecast, by Application
  • 15.5.5 Latin America Market Size and Forecast, by Technology
  • 15.5.6 Latin America Market Size and Forecast, by End User
  • 15.5.7 Latin America Market Size and Forecast, by Process
  • 15.5.8 Latin America Market Size and Forecast, by Mode
  • 15.5.9 Latin America Market Size and Forecast, by Stage
  • 15.5.10 Latin America Market Size and Forecast, by Country
  • 15.5.11 Brazil
    • 15.5.9.1 Brazil Market Size and Forecast, by Type
    • 15.5.9.2 Brazil Market Size and Forecast, by Product
    • 15.5.9.3 Brazil Market Size and Forecast, by Application
    • 15.5.9.4 Brazil Market Size and Forecast, by Technology
    • 15.5.9.5 Brazil Market Size and Forecast, by End User
    • 15.5.9.6 Brazil Market Size and Forecast, by Process
    • 15.5.9.7 Brazil Market Size and Forecast, by Mode
    • 15.5.9.8 Brazil Market Size and Forecast, by Stage
    • 15.5.9.9 Local Competition Analysis
    • 15.5.9.10 Local Market Analysis
  • 15.5.1 Mexico
    • 15.5.10.1 Mexico Market Size and Forecast, by Type
    • 15.5.10.2 Mexico Market Size and Forecast, by Product
    • 15.5.10.3 Mexico Market Size and Forecast, by Application
    • 15.5.10.4 Mexico Market Size and Forecast, by Technology
    • 15.5.10.5 Mexico Market Size and Forecast, by End User
    • 15.5.10.6 Mexico Market Size and Forecast, by Process
    • 15.5.10.7 Mexico Market Size and Forecast, by Mode
    • 15.5.10.8 Mexico Market Size and Forecast, by Stage
    • 15.5.10.9 Local Competition Analysis
    • 15.5.10.10 Local Market Analysis
  • 15.5.1 Argentina
    • 15.5.11.1 Argentina Market Size and Forecast, by Type
    • 15.5.11.2 Argentina Market Size and Forecast, by Product
    • 15.5.11.3 Argentina Market Size and Forecast, by Application
    • 15.5.11.4 Argentina Market Size and Forecast, by Technology
    • 15.5.11.5 Argentina Market Size and Forecast, by End User
    • 15.5.11.6 Argentina Market Size and Forecast, by Process
    • 15.5.11.7 Argentina Market Size and Forecast, by Mode
    • 15.5.11.8 Argentina Market Size and Forecast, by Stage
    • 15.5.11.9 Local Competition Analysis
    • 15.5.11.10 Local Market Analysis
  • 15.5.1 Rest of Latin America
    • 15.5.12.1 Rest of Latin America Market Size and Forecast, by Type
    • 15.5.12.2 Rest of Latin America Market Size and Forecast, by Product
    • 15.5.12.3 Rest of Latin America Market Size and Forecast, by Application
    • 15.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
    • 15.5.12.5 Rest of Latin America Market Size and Forecast, by End User
    • 15.5.12.6 Rest of Latin America Market Size and Forecast, by Process
    • 15.5.12.7 Rest of Latin America Market Size and Forecast, by Mode
    • 15.5.12.8 Rest of Latin America Market Size and Forecast, by Stage
    • 15.5.12.9 Local Competition Analysis
    • 15.5.12.10 Local Market Analysis
• 15.1 Middle East and Africa
  • 15.6.1 Key Market Trends and Opportunities
  • 15.6.2 Middle East and Africa Market Size and Forecast, by Type
  • 15.6.3 Middle East and Africa Market Size and Forecast, by Product
  • 15.6.4 Middle East and Africa Market Size and Forecast, by Application
  • 15.6.5 Middle East and Africa Market Size and Forecast, by Technology
  • 15.6.6 Middle East and Africa Market Size and Forecast, by End User
  • 15.6.7 Middle East and Africa Market Size and Forecast, by Process
  • 15.6.8 Middle East and Africa Market Size and Forecast, by Mode
  • 15.6.9 Middle East and Africa Market Size and Forecast, by Stage
  • 15.6.10 Middle East and Africa Market Size and Forecast, by Country
  • 15.6.11 Saudi Arabia
    • 15.6.9.1 Saudi Arabia Market Size and Forecast, by Type
    • 15.6.9.2 Saudi Arabia Market Size and Forecast, by Product
    • 15.6.9.3 Saudi Arabia Market Size and Forecast, by Application
    • 15.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
    • 15.6.9.5 Saudi Arabia Market Size and Forecast, by End User
    • 15.6.9.6 Saudi Arabia Market Size and Forecast, by Process
    • 15.6.9.7 Saudi Arabia Market Size and Forecast, by Mode
    • 15.6.9.8 Saudi Arabia Market Size and Forecast, by Stage
    • 15.6.9.9 Local Competition Analysis
    • 15.6.9.10 Local Market Analysis
  • 15.6.1 UAE
    • 15.6.10.1 UAE Market Size and Forecast, by Type
    • 15.6.10.2 UAE Market Size and Forecast, by Product
    • 15.6.10.3 UAE Market Size and Forecast, by Application
    • 15.6.10.4 UAE Market Size and Forecast, by Technology
    • 15.6.10.5 UAE Market Size and Forecast, by End User
    • 15.6.10.6 UAE Market Size and Forecast, by Process
    • 15.6.10.7 UAE Market Size and Forecast, by Mode
    • 15.6.10.8 UAE Market Size and Forecast, by Stage
    • 15.6.10.9 Local Competition Analysis
    • 15.6.10.10 Local Market Analysis
  • 15.6.1 South Africa
    • 15.6.11.1 South Africa Market Size and Forecast, by Type
    • 15.6.11.2 South Africa Market Size and Forecast, by Product
    • 15.6.11.3 South Africa Market Size and Forecast, by Application
    • 15.6.11.4 South Africa Market Size and Forecast, by Technology
    • 15.6.11.5 South Africa Market Size and Forecast, by End User
    • 15.6.11.6 South Africa Market Size and Forecast, by Process
    • 15.6.11.7 South Africa Market Size and Forecast, by Mode
    • 15.6.11.8 South Africa Market Size and Forecast, by Stage
    • 15.6.11.9 Local Competition Analysis
    • 15.6.11.10 Local Market Analysis
  • 15.6.1 Rest of MEA
    • 15.6.12.1 Rest of MEA Market Size and Forecast, by Type
    • 15.6.12.2 Rest of MEA Market Size and Forecast, by Product
    • 15.6.12.3 Rest of MEA Market Size and Forecast, by Application
    • 15.6.12.4 Rest of MEA Market Size and Forecast, by Technology
    • 15.6.12.5 Rest of MEA Market Size and Forecast, by End User
    • 15.6.12.6 Rest of MEA Market Size and Forecast, by Process
    • 15.6.12.7 Rest of MEA Market Size and Forecast, by Mode
    • 15.6.12.8 Rest of MEA Market Size and Forecast, by Stage
    • 15.6.12.9 Local Competition Analysis
    • 15.6.12.10 Local Market Analysis

16: Competitive Landscape

• 16.1 Overview
• 16.2 Market Share Analysis
• 16.3 Key Player Positioning
• 16.4 Competitive Leadership Mapping
  • 16.4.1 Star Players
  • 16.4.2 Innovators
  • 16.4.3 Emerging Players
• 16.5 Vendor Benchmarking
• 16.6 Developmental Strategy Benchmarking
  • 16.6.1 New Product Developments
  • 16.6.2 Product Launches
  • 16.6.3 Business Expansions
  • 16.6.4 Partnerships, Joint Ventures, and Collaborations
  • 16.6.5 Mergers and Acquisitions

17: Company Profiles

• 17.1 Incyte
  • 17.1.1 Company Overview
  • 17.1.2 Company Snapshot
  • 17.1.3 Business Segments
  • 17.1.4 Business Performance
  • 17.1.5 Product Offerings
  • 17.1.6 Key Developmental Strategies
  • 17.1.7 SWOT Analysis
• 17.2 BeiGene
  • 17.2.1 Company Overview
  • 17.2.2 Company Snapshot
  • 17.2.3 Business Segments
  • 17.2.4 Business Performance
  • 17.2.5 Product Offerings
  • 17.2.6 Key Developmental Strategies
  • 17.2.7 SWOT Analysis
• 17.3 MacroGenics
  • 17.3.1 Company Overview
  • 17.3.2 Company Snapshot
  • 17.3.3 Business Segments
  • 17.3.4 Business Performance
  • 17.3.5 Product Offerings
  • 17.3.6 Key Developmental Strategies
  • 17.3.7 SWOT Analysis
• 17.4 Adaptimmune Therapeutics
  • 17.4.1 Company Overview
  • 17.4.2 Company Snapshot
  • 17.4.3 Business Segments
  • 17.4.4 Business Performance
  • 17.4.5 Product Offerings
  • 17.4.6 Key Developmental Strategies
  • 17.4.7 SWOT Analysis
• 17.5 Immunomedics
  • 17.5.1 Company Overview
  • 17.5.2 Company Snapshot
  • 17.5.3 Business Segments
  • 17.5.4 Business Performance
  • 17.5.5 Product Offerings
  • 17.5.6 Key Developmental Strategies
  • 17.5.7 SWOT Analysis
• 17.6 Kite Pharma
  • 17.6.1 Company Overview
  • 17.6.2 Company Snapshot
  • 17.6.3 Business Segments
  • 17.6.4 Business Performance
  • 17.6.5 Product Offerings
  • 17.6.6 Key Developmental Strategies
  • 17.6.7 SWOT Analysis
• 17.7 Juno Therapeutics
  • 17.7.1 Company Overview
  • 17.7.2 Company Snapshot
  • 17.7.3 Business Segments
  • 17.7.4 Business Performance
  • 17.7.5 Product Offerings
  • 17.7.6 Key Developmental Strategies
  • 17.7.7 SWOT Analysis
• 17.8 Immunocore
  • 17.8.1 Company Overview
  • 17.8.2 Company Snapshot
  • 17.8.3 Business Segments
  • 17.8.4 Business Performance
  • 17.8.5 Product Offerings
  • 17.8.6 Key Developmental Strategies
  • 17.8.7 SWOT Analysis
• 17.9 Bluebird Bio
  • 17.9.1 Company Overview
  • 17.9.2 Company Snapshot
  • 17.9.3 Business Segments
  • 17.9.4 Business Performance
  • 17.9.5 Product Offerings
  • 17.9.6 Key Developmental Strategies
  • 17.9.7 SWOT Analysis
• 17.10 Celldex Therapeutics
  • 17.10.1 Company Overview
  • 17.10.2 Company Snapshot
  • 17.10.3 Business Segments
  • 17.10.4 Business Performance
  • 17.10.5 Product Offerings
  • 17.10.6 Key Developmental Strategies
  • 17.10.7 SWOT Analysis
• 17.11 OncoMed Pharmaceuticals
  • 17.11.1 Company Overview
  • 17.11.2 Company Snapshot
  • 17.11.3 Business Segments
  • 17.11.4 Business Performance
  • 17.11.5 Product Offerings
  • 17.11.6 Key Developmental Strategies
  • 17.11.7 SWOT Analysis
• 17.12 Argenx
  • 17.12.1 Company Overview
  • 17.12.2 Company Snapshot
  • 17.12.3 Business Segments
  • 17.12.4 Business Performance
  • 17.12.5 Product Offerings
  • 17.12.6 Key Developmental Strategies
  • 17.12.7 SWOT Analysis
• 17.13 Cellectis
  • 17.13.1 Company Overview
  • 17.13.2 Company Snapshot
  • 17.13.3 Business Segments
  • 17.13.4 Business Performance
  • 17.13.5 Product Offerings
  • 17.13.6 Key Developmental Strategies
  • 17.13.7 SWOT Analysis
• 17.14 Fate Therapeutics
  • 17.14.1 Company Overview
  • 17.14.2 Company Snapshot
  • 17.14.3 Business Segments
  • 17.14.4 Business Performance
  • 17.14.5 Product Offerings
  • 17.14.6 Key Developmental Strategies
  • 17.14.7 SWOT Analysis
• 17.15 Gritstone Oncology
  • 17.15.1 Company Overview
  • 17.15.2 Company Snapshot
  • 17.15.3 Business Segments
  • 17.15.4 Business Performance
  • 17.15.5 Product Offerings
  • 17.15.6 Key Developmental Strategies
  • 17.15.7 SWOT Analysis
• 17.16 Adaptimmune
  • 17.16.1 Company Overview
  • 17.16.2 Company Snapshot
  • 17.16.3 Business Segments
  • 17.16.4 Business Performance
  • 17.16.5 Product Offerings
  • 17.16.6 Key Developmental Strategies
  • 17.16.7 SWOT Analysis
• 17.17 Allogene Therapeutics
  • 17.17.1 Company Overview
  • 17.17.2 Company Snapshot
  • 17.17.3 Business Segments
  • 17.17.4 Business Performance
  • 17.17.5 Product Offerings
  • 17.17.6 Key Developmental Strategies
  • 17.17.7 SWOT Analysis
• 17.18 Iovance Biotherapeutics
  • 17.18.1 Company Overview
  • 17.18.2 Company Snapshot
  • 17.18.3 Business Segments
  • 17.18.4 Business Performance
  • 17.18.5 Product Offerings
  • 17.18.6 Key Developmental Strategies
  • 17.18.7 SWOT Analysis
• 17.19 Zymeworks
  • 17.19.1 Company Overview
  • 17.19.2 Company Snapshot
  • 17.19.3 Business Segments
  • 17.19.4 Business Performance
  • 17.19.5 Product Offerings
  • 17.19.6 Key Developmental Strategies
  • 17.19.7 SWOT Analysis
• 17.20 Compugen
  • 17.20.1 Company Overview
  • 17.20.2 Company Snapshot
  • 17.20.3 Business Segments
  • 17.20.4 Business Performance
  • 17.20.5 Product Offerings
  • 17.20.6 Key Developmental Strategies
  • 17.20.7 SWOT Analysis